Zeno Pharmaceuticals, Inc.
1 clinical trials · Sponsor
◉ Watch Zeno Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of ZN-e4 in Subjects With Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung Cancer (NCT03446417) | Zeno Pharmaceuticals, Inc. | 2018-04-20 |
Track Zeno Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.